{"id":621,"date":"2024-12-02T09:23:51","date_gmt":"2024-12-02T05:53:51","guid":{"rendered":"https:\/\/straumanniran.com\/fa\/?page_id=621"},"modified":"2025-07-15T14:44:08","modified_gmt":"2025-07-15T11:14:08","slug":"glossary-of-abbreviations","status":"publish","type":"page","link":"https:\/\/straumanniran.com\/fa\/glossary-of-abbreviations\/","title":{"rendered":"\u0648\u0627\u0698\u0647 \u0646\u0627\u0645\u0647 \u0627\u062e\u062a\u0635\u0627\u0631\u0627\u062a \u0627\u0634\u062a\u0631\u0648\u0645\u0646"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

A<\/span><\/h2>\n

ABUTMENT\u00a0<\/b>
\nA component that connects the implant with the prosthesis and protrudes into the oral cavity.<\/p>\n

AMORTIZATION\u202f<\/b>
\nSystematic allocation of the depreciable amount of an intangible asset over its useful life<\/p>\n

ASSOCIATES\u00a0<\/b>
\nAssociates are those entities over which the Group has significant influence, but neither control nor joint control.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

B<\/span><\/h2>\n

BONECERAMIC<\/b>
\nStraumann\u2019s fully synthetic bone substitute for bone augmentation procedures<\/p>\n

BONE LEVEL IMPLANT \u00a0<\/b>
\nImplant where the connection between the implant and the abutment is placed at the level of the bone crest<\/p>\n

BRIDGE<\/b>
\nAn appliance used to bridge the gap created by missing teeth by using one or more false teeth fixed to crowns anchored to tooth stumps or implants<\/p>\n

BUSINESS COMBINATION\u00a0<\/b>
\nA transaction\/event in which an acquirer obtains control of one or more businesses<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

C<\/span><\/h2>\n

CADCAM<\/b>
\nComputer Aided Design\/Computer Aided Manufacturing, a computer system is used both for designing a product and for controlling manufacturing processes<\/p>\n

CAGR\u202f<\/b>
\nCompound Annual Growth Rate, annualized growth rate over a multiple year period<\/p>\n

CNC LATHE<\/b>
\nComputerized Numerically Controlled lathe used to machine implants and other components<\/p>\n

CONSISTENT EMERGENCE PROFILES<\/b>
\nOptimized and uniform soft tissue management through prosthetic components<\/p>\n

COPING<\/b>
\nA covering or cap that fits on an abutment and is usually made of metal, ceramic or plastic<\/p>\n

CORE\u00a0<\/b>
\nResults presented in addition to the figures reported under IFRS to facilitate a like-for-like comparison (Alternative Performance Measures)<\/p>\n

CROSSFIT<\/b>
\nStraumann\u2019s self-guiding internal implant-abutment connection, featuring four internal grooves that prevent rotation and ensure precise fit and a conical interface for lasting mechanical stability<\/p>\n

CROWN<\/b>
\nA tooth-shaped \u201ccap\u201d restoration attached to a tooth stump or implant abutment<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

D<\/span><\/h2>\n

DENTAL TECHNICIAN<\/b>
\nDental professional who manufactures patient-specific crowns, bridges, dentures and other dental and oral prostheses according to the specifications of the dentist<\/p>\n

DEPRECIATION\u202f<\/b>
\nSystematic allocation of the depreciable amount of a tangible asset<\/p>\n

BASIC EARNINGS PER SHARE (EPS)\u202f<\/b>
\nNet profit attributable to shareholders of Straumann Holding AG divided by the weighted average number of shares outstanding<\/p>\n

DILUTED EARNINGS PER SHARE<\/b>
\nNet profit attributable to shareholders of Straumann Holding AG divided by the weighted average number of shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential of outstanding equity instruments into ordinary shares.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

E<\/span><\/h2>\n

EBIT\u202f<\/b>
\nEarnings before interest and taxes; also referred to here as operating profit<\/p>\n

EBITDA\u202f<\/b>
\nEarnings before interest, taxes, depreciation and amortization<\/p>\n

EBIT MARGIN\u202f<\/b>
\nOperating profit (EBIT) divided by group revenues in %<\/p>\n

ECONOMIC PROFIT\u202f<\/b>
\n(EP) See compensation report in Straumann\u2019s Annual report<\/p>\n

EDENTULOUS<\/b>
\nHaving fewer teeth than normal, which may include full edentulism<\/p>\n

EMDOGAIN (ENAMEL MATRIX DERIVATIVE)<\/b>
\neasy-to-use unique gel containing enamel matrix derivative. Straumann\u00ae Emdogain\u00ae forms a matrix that stimulates cells and processes that are fundamental for tissue regeneration which provides improved long-term clinical results with increased patient comfort.<\/p>\n

ENDODONTICS<\/b>
\nBranch of dentistry concerned with the etiology, prevention, diagnosis and treatment of diseases and injuries that affect the dental pulp, tooth root and periapical tissues<\/p>\n

ERP<\/b>
\nEnterprise Resource Planning<\/p>\n

EQUITY RATIO\u202f<\/b>
\nTotal equity divided by total assets in %<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

F<\/span><\/h2>\n

FREE CASH FLOW
\n<\/b>Net cash from operating activities less purchase of property, plant and equipment, less purchase of intangible assets, plus net proceeds from property, plant and equipment.<\/p>\n

FREE CASH FLOW MARGIN\u202f<\/b>
\nFree cash flow divided by group revenues in %<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

G<\/span><\/h2>\n

GBR<\/b>
\nGuided Bone Regeneration<\/p>\n

GLASS CERAMICS<\/b>
\nCeramic of lithium disilicate or similar high-performance material that combines strength with translucence; examples include Ivoclar Vivadent\u2019s IPS e.max<\/p>\n

GOODWILL\u202f<\/b>
\nFuture economic benefits arising from assets that are not capable of being individually identified and separately recognized<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

H<\/span><\/h2>\n

HYDROPHILIC<\/b>
\nReadily absorbing or attracting water, or having chemical groups that interact with water<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

I<\/span><\/h2>\n

IMPAIRMENT LOSS\u202f<\/b>
\nAn impairment loss is the amount by which the carrying amount of an asset or a cash-generating unit exceeds its recoverable value<\/p>\n

INLAY<\/b>
\nA pre-fabricated individualized restoration cemented into a tooth to restore its shape.<\/p>\n

IFRS<\/b>
\nInternational Financial Reporting Standards<\/p>\n

IMPLANT LOADING<\/b>
\nSubjecting an implant to biting pressure by fitting a temporary\/ permanent crown<\/p>\n

ITI<\/b>
\nInternational Team for Implantology<\/p>\n

IMPLANT LOADING<\/b>
\nSubjecting an implant to biting pressure by fitting a temporary\/ permanent crown<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

M<\/span><\/h2>\n

MEMBRANE<\/b>
\nA barrier used e.g. in GBR to prevent rapidly growing soft tissue from occupying space into which new bone should form, and to stabilize bone augmentation materials<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

N<\/span><\/h2>\n

NET PROFIT MARGIN\u202f<\/b>
\nNet profit divided by group revenues in %<\/p>\n

NIS<\/b>
\nNon-interventional study, designed to evaluate products in everyday clinical settings in a wide range of patients, where the clinician can use the product however deemed suitable, provided that treatment guidelines are followed<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

O<\/span><\/h2>\n

ONE-STAGE PROCEDURE<\/b>
\nSurgical procedure whereby the implant is placed but not covered by the gum tissue during healing, so no second surgical procedure is necessary to uncover the implant<\/p>\n

ORGANIC GROWTH
\n<\/b>Organic growth is the growth excluding effect from business combinations and currency effects<\/b><\/p>\n

ORTHODONTICS
\n<\/b>Branch of dentistry concerned with the correction of misaligned teeth using appliances designed to move the teeth into a more favorable position over a period of time<\/b><\/p>\n

OSSEOINTEGRATION \u00a0<\/b>
\nThe integration of an implant with the surrounding bone<\/p>\n

OSTEOCONDUCTIVE<\/b>
\nAn osteoconductive substance has the ability to act as a scaffold to which bone cells can attach, initiating bone growth<\/p>\n

OSTEOINDUCTIVE<\/b>
\nA substance with the ability to induce bone growth<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

P<\/span><\/h2>\n

PAY-OUT RATIO\u202f<\/b>
\nPercentage of earnings paid to shareholders of Straumann Holding AG as a dividend<\/p>\n

PERI-IMPLANTITIS<\/b>
\nInflammatory tissue pathology and progressive bone loss at implant site resulting from plaque accumulation and bacterial infiltration around dental implants<\/p>\n

PERIODONTICS<\/b>
\nBranch of dentistry concerned with the care and treatment of the supporting tissues of the teeth from gingival to the adjacent alveolar bone and ligament<\/p>\n

PERIODONTIST<\/b>
\nDental professional specialized in the periodontal tissue and bone surrounding the teeth and in treating diseases that affect them<\/p>\n

PERIODONTITIS<\/b>
\nProgressive disease of the periodontal tissues, which may result in the gradual loss of the tooth and supporting structures<\/p>\n

POLYETHYLENE GLYCOL (PEG)<\/b>
\nA hydrophilic polymer (macromolecule of repeating units) that interacts with cell membranes and promotes fusion of cells<\/p>\n

PPA\u00a0<\/b>
\nPurchase Price Allocation; allocation of the purchase price to the assets and liabilities of a business acquired in a business combination<\/p>\n

PRE-SHAPED ANATOMIC ABUTMENT<\/b>
\nAbutment designed with the anatomical considerations of the periodontal tissue as well as occlusal and functional aspects in mind, and for modification by both the technician and dentist<\/p>\n

PROSTHODONTIST<\/b>
\nA dental professional who restores and rehabilitates the dentition, craniofacial, craniomandibular and masticatory function of patients<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

R<\/span><\/h2>\n

RCT<\/b>
\nRandomized controlled trial<\/p>\n

RESTORATIVE DENTISTRY<\/b>
\nBranch of dentistry concerned with the replacement or reconstruction of the dentition<\/p>\n

RIGHT-OF-USE-ASSETS\u00a0<\/b>
\nAn asset that represents a lessee\u2019s right to use an underlying asset for the lease term.<\/p>\n

ROA\u202f<\/b>
\nReturn on assets; net profit divided by average assets in %<\/p>\n

ROCE\u202f<\/b>
\nReturn on capital employed; earnings before interest and taxes divided by average capital employed in %<\/p>\n

ROE\u202f<\/b>
\nReturn on equity; net profit divided by average equity in %<\/p>\n

ROXOLID<\/b>
\nStraumann\u2019s proprietary alloy of titanium and zirconium, which combines high tensile and fatigue strengths with excellent osseointragration – particulary useful in smaller diameter implants.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

S<\/span><\/h2>\n

SLA<\/b>
\nImplant surface which is sand blasted with Large grit and Acid etched.<\/p>\n

TOTAL SHAREHOLDER RETURN (TSR)\u202f<\/b>
\nProfit or loss realized by an investor for a specific period. TSR includes capital gains\/losses from increases\/decreases in stock price as well as dividends received.<\/p>\n

SLA<\/b>
\nrefers to Straumann\u2019s second-generation implant surface technology introduced in 1998, which \u2013 with the exception of SLActive \u2013 is the gold standard in terms of osseointegration time.<\/p>\n

SLACTIVE<\/b>
\nStraumann\u2019s third-generation implant surface technology with extensive healing potential. It stands for high predictability and accelerated osseointegration. Recent studies show an outstanding clinical performance of SLActive\u00ae implants even in very challenging treatment protocols and patients with compromised health.<\/p>\n

SUBSIDIARIES\u00a0<\/b>
\nSubsidiaries are entities controlled by the Group.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

T<\/span><\/h2>\n

TISSUE LEVEL IMPLANT<\/b>
\nImplant where the connection between the implant and the abutment is placed at the level of the soft tissue, so that the soft tissue surrounds the polished collar of the implant<\/p>\n

TITANIUM<\/b>
\nMetallic substance isolated from minerals as an iron-gray powder; available in many forms and used in many dental and orthopedic applications<\/p>\n

TWO-STAGE PROCEDURE<\/b>
\nSurgical procedure whereby the implant is inserted and a healing cap placed, which is covered by the gum tissue during healing; a second surgical procedure is performed later, where the healing cap is removed and an abutment and provisional prosthesis placed<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

W<\/span><\/h2>\n

WACC\u202f<\/b>
\nWeighted average cost of capital<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

\n
\n
\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

Z<\/span><\/h2>\n

ZERION<\/b>
\netkon\u2019s 100% metal-free, biocompatible, full-ceramic zirconium oxide for customized reconstructions ZIRCONIA ZrO2 \u2013 the white oxide of zirconium used on account of its infusibility and luminosity in dental prosthetics, enamels and glazes<\/p>\n

ZIRCONIUM<\/b>
\nA grayish-white, strong, ductile metallic element obtained from zircon and used in ceramic and refractory compounds as an alloying agent<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

A ABUTMENT\u00a0 A component that connects the implant with the prosthesis and protrudes into the oral cavity. AMORTIZATION\u202f Systematic allocation of the depreciable amount of an intangible asset over its useful life ASSOCIATES\u00a0 Associates are those entities over which the Group has significant influence, but neither control nor joint control. B BONECERAMIC Straumann\u2019s fully synthetic […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-621","page","type-page","status-publish","hentry"],"acf":[],"rankMath":{"parentDomain":"straumanniran.com","noFollowDomains":[],"noFollowExcludeDomains":[],"noFollowExternalLinks":false,"featuredImageNotice":"\u062a\u0635\u0648\u06cc\u0631 \u0634\u0627\u062e\u0635 \u0628\u0627\u06cc\u062f \u062d\u062f\u0627\u0642\u0644 200 \u062f\u0631 200 \u067e\u06cc\u06a9\u0633\u0644 \u0628\u0627\u0634\u062f \u062a\u0627 \u062a\u0648\u0633\u0637 \u0641\u06cc\u0633\u0628\u0648\u06a9 \u0648 \u0633\u0627\u06cc\u0631 \u0633\u0627\u06cc\u062a\u200c\u0647\u0627\u06cc \u0631\u0633\u0627\u0646\u0647\u200c\u0647\u0627\u06cc \u0627\u062c\u062a\u0645\u0627\u0639\u06cc \u0642\u0627\u0628\u0644 \u0627\u0633\u062a\u0641\u0627\u062f\u0647 \u0628\u0627\u0634\u062f.","pluginReviewed":false,"postSettings":{"linkSuggestions":true,"useFocusKeyword":false},"frontEndScore":false,"postName":"glossary-of-abbreviations","permalinkFormat":"https:\/\/straumanniran.com\/fa\/%pagename%\/","showLockModifiedDate":true,"assessor":{"focusKeywordLink":"https:\/\/straumanniran.com\/fa\/wp-admin\/edit.php?focus_keyword=%focus_keyword%&post_type=%post_type%","hasTOCPlugin":true,"primaryTaxonomy":false,"serpData":{"title":"","description":"\u062f\u0631 \u0627\u06cc\u0646\u062c\u0627 \u0648\u0627\u0698\u0647 \u0646\u0627\u0645\u0647 \u0627\u062e\u062a\u0635\u0627\u0631\u0627\u062a \u0627\u0634\u062a\u0631\u0648\u0645\u0646\u060c \u0646\u0626\u0648\u062f\u0646\u062a \u0648 \u0627\u06cc\u0645\u067e\u0644\u0646\u062a\u0648\u0644\u0648\u0698\u06cc \u0631\u0627 \u0645\u0637\u0627\u0644\u0639\u0647 \u0641\u0631\u0645\u0627\u06cc\u06cc\u062f.","focusKeywords":"\u0648\u0627\u0698\u0647 \u0646\u0627\u0645\u0647 \u0627\u062e\u062a\u0635\u0627\u0631\u0627\u062a \u0627\u0634\u062a\u0631\u0648\u0645\u0646,\u0648\u0627\u0698\u0647 \u0646\u0627\u0645\u0647 \u0627\u062e\u062a\u0635\u0627\u0631\u0627\u062a,\u0627\u0634\u062a\u0631\u0648\u0645\u0646,\u0646\u0626\u0648\u062f\u0646\u062a,\u0627\u06cc\u0645\u067e\u0644\u0646\u062a","pillarContent":false,"canonicalUrl":"","breadcrumbTitle":"","advancedRobots":[],"facebookTitle":"","facebookDescription":"","facebookImage":"","facebookImageID":"","facebookHasOverlay":false,"facebookImageOverlay":"","facebookAuthor":"","twitterCardType":"","twitterUseFacebook":true,"twitterTitle":"","twitterDescription":"","twitterImage":"","twitterImageID":"","twitterHasOverlay":false,"twitterImageOverlay":"","twitterPlayerUrl":"","twitterPlayerSize":"","twitterPlayerStream":"","twitterPlayerStreamCtype":"","twitterAppDescription":"","twitterAppIphoneName":"","twitterAppIphoneID":"","twitterAppIphoneUrl":"","twitterAppIpadName":"","twitterAppIpadID":"","twitterAppIpadUrl":"","twitterAppGoogleplayName":"","twitterAppGoogleplayID":"","twitterAppGoogleplayUrl":"","twitterAppCountry":"","robots":{"index":true},"twitterAuthor":"\u0646\u0627\u0645 \u06a9\u0627\u0631\u0628\u0631\u06cc","primaryTerm":0,"authorName":"\u0627\u0634\u062a\u0631\u0648\u0645\u0646 \u0627\u06cc\u0631\u0627\u0646","titleTemplate":"%title% %sep% %sitename%","descriptionTemplate":"%excerpt%","showScoreFrontend":true,"lockModifiedDate":false},"powerWords":[],"diacritics":{"A":"[\\u0041\\u24B6\\uFF21\\u00C0\\u00C1\\u00C2\\u1EA6\\u1EA4\\u1EAA\\u1EA8\\u00C3\\u0100\\u0102\\u1EB0\\u1EAE\\u1EB4\\u1EB2\\u0226\\u01E0\\u00C4\\u01DE\\u1EA2\\u00C5\\u01FA\\u01CD\\u0200\\u0202\\u1EA0\\u1EAC\\u1EB6\\u1E00\\u0104\\u023A\\u2C6F]","AA":"[\\uA732]","AE":"[\\u00C6\\u01FC\\u01E2]","AO":"[\\uA734]","AU":"[\\uA736]","AV":"[\\uA738\\uA73A]","AY":"[\\uA73C]","B":"[\\u0042\\u24B7\\uFF22\\u1E02\\u1E04\\u1E06\\u0243\\u0182\\u0181]","C":"[\\u0043\\u24B8\\uFF23\\u0106\\u0108\\u010A\\u010C\\u00C7\\u1E08\\u0187\\u023B\\uA73E]","D":"[\\u0044\\u24B9\\uFF24\\u1E0A\\u010E\\u1E0C\\u1E10\\u1E12\\u1E0E\\u0110\\u018B\\u018A\\u0189\\uA779]","DZ":"[\\u01F1\\u01C4]","Dz":"[\\u01F2\\u01C5]","E":"[\\u0045\\u24BA\\uFF25\\u00C8\\u00C9\\u00CA\\u1EC0\\u1EBE\\u1EC4\\u1EC2\\u1EBC\\u0112\\u1E14\\u1E16\\u0114\\u0116\\u00CB\\u1EBA\\u011A\\u0204\\u0206\\u1EB8\\u1EC6\\u0228\\u1E1C\\u0118\\u1E18\\u1E1A\\u0190\\u018E]","F":"[\\u0046\\u24BB\\uFF26\\u1E1E\\u0191\\uA77B]","G":"[\\u0047\\u24BC\\uFF27\\u01F4\\u011C\\u1E20\\u011E\\u0120\\u01E6\\u0122\\u01E4\\u0193\\uA7A0\\uA77D\\uA77E]","H":"[\\u0048\\u24BD\\uFF28\\u0124\\u1E22\\u1E26\\u021E\\u1E24\\u1E28\\u1E2A\\u0126\\u2C67\\u2C75\\uA78D]","I":"[\\u0049\\u24BE\\uFF29\\u00CC\\u00CD\\u00CE\\u0128\\u012A\\u012C\\u0130\\u00CF\\u1E2E\\u1EC8\\u01CF\\u0208\\u020A\\u1ECA\\u012E\\u1E2C\\u0197]","J":"[\\u004A\\u24BF\\uFF2A\\u0134\\u0248]","K":"[\\u004B\\u24C0\\uFF2B\\u1E30\\u01E8\\u1E32\\u0136\\u1E34\\u0198\\u2C69\\uA740\\uA742\\uA744\\uA7A2]","L":"[\\u004C\\u24C1\\uFF2C\\u013F\\u0139\\u013D\\u1E36\\u1E38\\u013B\\u1E3C\\u1E3A\\u0141\\u023D\\u2C62\\u2C60\\uA748\\uA746\\uA780]","LJ":"[\\u01C7]","Lj":"[\\u01C8]","M":"[\\u004D\\u24C2\\uFF2D\\u1E3E\\u1E40\\u1E42\\u2C6E\\u019C]","N":"[\\u004E\\u24C3\\uFF2E\\u01F8\\u0143\\u00D1\\u1E44\\u0147\\u1E46\\u0145\\u1E4A\\u1E48\\u0220\\u019D\\uA790\\uA7A4]","NJ":"[\\u01CA]","Nj":"[\\u01CB]","O":"[\\u004F\\u24C4\\uFF2F\\u00D2\\u00D3\\u00D4\\u1ED2\\u1ED0\\u1ED6\\u1ED4\\u00D5\\u1E4C\\u022C\\u1E4E\\u014C\\u1E50\\u1E52\\u014E\\u022E\\u0230\\u00D6\\u022A\\u1ECE\\u0150\\u01D1\\u020C\\u020E\\u01A0\\u1EDC\\u1EDA\\u1EE0\\u1EDE\\u1EE2\\u1ECC\\u1ED8\\u01EA\\u01EC\\u00D8\\u01FE\\u0186\\u019F\\uA74A\\uA74C]","OI":"[\\u01A2]","OO":"[\\uA74E]","OU":"[\\u0222]","P":"[\\u0050\\u24C5\\uFF30\\u1E54\\u1E56\\u01A4\\u2C63\\uA750\\uA752\\uA754]","Q":"[\\u0051\\u24C6\\uFF31\\uA756\\uA758\\u024A]","R":"[\\u0052\\u24C7\\uFF32\\u0154\\u1E58\\u0158\\u0210\\u0212\\u1E5A\\u1E5C\\u0156\\u1E5E\\u024C\\u2C64\\uA75A\\uA7A6\\uA782]","S":"[\\u0053\\u24C8\\uFF33\\u1E9E\\u015A\\u1E64\\u015C\\u1E60\\u0160\\u1E66\\u1E62\\u1E68\\u0218\\u015E\\u2C7E\\uA7A8\\uA784]","T":"[\\u0054\\u24C9\\uFF34\\u1E6A\\u0164\\u1E6C\\u021A\\u0162\\u1E70\\u1E6E\\u0166\\u01AC\\u01AE\\u023E\\uA786]","TZ":"[\\uA728]","U":"[\\u0055\\u24CA\\uFF35\\u00D9\\u00DA\\u00DB\\u0168\\u1E78\\u016A\\u1E7A\\u016C\\u00DC\\u01DB\\u01D7\\u01D5\\u01D9\\u1EE6\\u016E\\u0170\\u01D3\\u0214\\u0216\\u01AF\\u1EEA\\u1EE8\\u1EEE\\u1EEC\\u1EF0\\u1EE4\\u1E72\\u0172\\u1E76\\u1E74\\u0244]","V":"[\\u0056\\u24CB\\uFF36\\u1E7C\\u1E7E\\u01B2\\uA75E\\u0245]","VY":"[\\uA760]","W":"[\\u0057\\u24CC\\uFF37\\u1E80\\u1E82\\u0174\\u1E86\\u1E84\\u1E88\\u2C72]","X":"[\\u0058\\u24CD\\uFF38\\u1E8A\\u1E8C]","Y":"[\\u0059\\u24CE\\uFF39\\u1EF2\\u00DD\\u0176\\u1EF8\\u0232\\u1E8E\\u0178\\u1EF6\\u1EF4\\u01B3\\u024E\\u1EFE]","Z":"[\\u005A\\u24CF\\uFF3A\\u0179\\u1E90\\u017B\\u017D\\u1E92\\u1E94\\u01B5\\u0224\\u2C7F\\u2C6B\\uA762]","a":"[\\u0061\\u24D0\\uFF41\\u1E9A\\u00E0\\u00E1\\u00E2\\u1EA7\\u1EA5\\u1EAB\\u1EA9\\u00E3\\u0101\\u0103\\u1EB1\\u1EAF\\u1EB5\\u1EB3\\u0227\\u01E1\\u00E4\\u01DF\\u1EA3\\u00E5\\u01FB\\u01CE\\u0201\\u0203\\u1EA1\\u1EAD\\u1EB7\\u1E01\\u0105\\u2C65\\u0250]","aa":"[\\uA733]","ae":"[\\u00E6\\u01FD\\u01E3]","ao":"[\\uA735]","au":"[\\uA737]","av":"[\\uA739\\uA73B]","ay":"[\\uA73D]","b":"[\\u0062\\u24D1\\uFF42\\u1E03\\u1E05\\u1E07\\u0180\\u0183\\u0253]","c":"[\\u0063\\u24D2\\uFF43\\u0107\\u0109\\u010B\\u010D\\u00E7\\u1E09\\u0188\\u023C\\uA73F\\u2184]","d":"[\\u0064\\u24D3\\uFF44\\u1E0B\\u010F\\u1E0D\\u1E11\\u1E13\\u1E0F\\u0111\\u018C\\u0256\\u0257\\uA77A]","dz":"[\\u01F3\\u01C6]","e":"[\\u0065\\u24D4\\uFF45\\u00E8\\u00E9\\u00EA\\u1EC1\\u1EBF\\u1EC5\\u1EC3\\u1EBD\\u0113\\u1E15\\u1E17\\u0115\\u0117\\u00EB\\u1EBB\\u011B\\u0205\\u0207\\u1EB9\\u1EC7\\u0229\\u1E1D\\u0119\\u1E19\\u1E1B\\u0247\\u025B\\u01DD]","f":"[\\u0066\\u24D5\\uFF46\\u1E1F\\u0192\\uA77C]","g":"[\\u0067\\u24D6\\uFF47\\u01F5\\u011D\\u1E21\\u011F\\u0121\\u01E7\\u0123\\u01E5\\u0260\\uA7A1\\u1D79\\uA77F]","h":"[\\u0068\\u24D7\\uFF48\\u0125\\u1E23\\u1E27\\u021F\\u1E25\\u1E29\\u1E2B\\u1E96\\u0127\\u2C68\\u2C76\\u0265]","hv":"[\\u0195]","i":"[\\u0069\\u24D8\\uFF49\\u00EC\\u00ED\\u00EE\\u0129\\u012B\\u012D\\u00EF\\u1E2F\\u1EC9\\u01D0\\u0209\\u020B\\u1ECB\\u012F\\u1E2D\\u0268\\u0131]","j":"[\\u006A\\u24D9\\uFF4A\\u0135\\u01F0\\u0249]","k":"[\\u006B\\u24DA\\uFF4B\\u1E31\\u01E9\\u1E33\\u0137\\u1E35\\u0199\\u2C6A\\uA741\\uA743\\uA745\\uA7A3]","l":"[\\u006C\\u24DB\\uFF4C\\u0140\\u013A\\u013E\\u1E37\\u1E39\\u013C\\u1E3D\\u1E3B\\u017F\\u0142\\u019A\\u026B\\u2C61\\uA749\\uA781\\uA747]","lj":"[\\u01C9]","m":"[\\u006D\\u24DC\\uFF4D\\u1E3F\\u1E41\\u1E43\\u0271\\u026F]","n":"[\\u006E\\u24DD\\uFF4E\\u01F9\\u0144\\u00F1\\u1E45\\u0148\\u1E47\\u0146\\u1E4B\\u1E49\\u019E\\u0272\\u0149\\uA791\\uA7A5]","nj":"[\\u01CC]","o":"[\\u006F\\u24DE\\uFF4F\\u00F2\\u00F3\\u00F4\\u1ED3\\u1ED1\\u1ED7\\u1ED5\\u00F5\\u1E4D\\u022D\\u1E4F\\u014D\\u1E51\\u1E53\\u014F\\u022F\\u0231\\u00F6\\u022B\\u1ECF\\u0151\\u01D2\\u020D\\u020F\\u01A1\\u1EDD\\u1EDB\\u1EE1\\u1EDF\\u1EE3\\u1ECD\\u1ED9\\u01EB\\u01ED\\u00F8\\u01FF\\u0254\\uA74B\\uA74D\\u0275]","oi":"[\\u01A3]","ou":"[\\u0223]","oo":"[\\uA74F]","p":"[\\u0070\\u24DF\\uFF50\\u1E55\\u1E57\\u01A5\\u1D7D\\uA751\\uA753\\uA755]","q":"[\\u0071\\u24E0\\uFF51\\u024B\\uA757\\uA759]","r":"[\\u0072\\u24E1\\uFF52\\u0155\\u1E59\\u0159\\u0211\\u0213\\u1E5B\\u1E5D\\u0157\\u1E5F\\u024D\\u027D\\uA75B\\uA7A7\\uA783]","s":"[\\u0073\\u24E2\\uFF53\\u015B\\u1E65\\u015D\\u1E61\\u0161\\u1E67\\u1E63\\u1E69\\u0219\\u015F\\u023F\\uA7A9\\uA785\\u1E9B]","ss":"[\\u00DF]","t":"[\\u0074\\u24E3\\uFF54\\u1E6B\\u1E97\\u0165\\u1E6D\\u021B\\u0163\\u1E71\\u1E6F\\u0167\\u01AD\\u0288\\u2C66\\uA787]","tz":"[\\uA729]","u":"[\\u0075\\u24E4\\uFF55\\u00F9\\u00FA\\u00FB\\u0169\\u1E79\\u016B\\u1E7B\\u016D\\u00FC\\u01DC\\u01D8\\u01D6\\u01DA\\u1EE7\\u016F\\u0171\\u01D4\\u0215\\u0217\\u01B0\\u1EEB\\u1EE9\\u1EEF\\u1EED\\u1EF1\\u1EE5\\u1E73\\u0173\\u1E77\\u1E75\\u0289]","v":"[\\u0076\\u24E5\\uFF56\\u1E7D\\u1E7F\\u028B\\uA75F\\u028C]","vy":"[\\uA761]","w":"[\\u0077\\u24E6\\uFF57\\u1E81\\u1E83\\u0175\\u1E87\\u1E85\\u1E98\\u1E89\\u2C73]","x":"[\\u0078\\u24E7\\uFF58\\u1E8B\\u1E8D]","y":"[\\u0079\\u24E8\\uFF59\\u1EF3\\u00FD\\u0177\\u1EF9\\u0233\\u1E8F\\u00FF\\u1EF7\\u1E99\\u1EF5\\u01B4\\u024F\\u1EFF]","z":"[\\u007A\\u24E9\\uFF5A\\u017A\\u1E91\\u017C\\u017E\\u1E93\\u1E95\\u01B6\\u0225\\u0240\\u2C6C\\uA763]"},"researchesTests":["contentHasTOC","contentHasShortParagraphs","contentHasAssets","keywordInTitle","keywordInMetaDescription","keywordInPermalink","keywordIn10Percent","keywordInContent","keywordInSubheadings","keywordInImageAlt","keywordDensity","keywordNotUsed","lengthContent","lengthPermalink","linksHasInternal","linksHasExternals","linksNotAllExternals","titleStartWithKeyword","titleSentiment","titleHasPowerWords","titleHasNumber","hasContentAI"],"hasRedirection":false,"hasBreadcrumb":false},"homeUrl":"https:\/\/straumanniran.com\/fa","objectID":621,"objectType":"post","locale":"fa","localeFull":"fa_IR","overlayImages":{"play":{"name":"\u0622\u06cc\u06a9\u0648\u0646 \u067e\u062e\u0634","url":"https:\/\/straumanniran.com\/fa\/wp-content\/plugins\/seo-by-rank-math1\/assets\/admin\/img\/icon-play.png","path":"\/home\/strauman\/public_html\/fa\/wp-content\/plugins\/seo-by-rank-math1\/assets\/admin\/img\/icon-play.png","position":"middle_center"},"gif":{"name":"\u0622\u06cc\u06a9\u0648\u0646 GIF","url":"https:\/\/straumanniran.com\/fa\/wp-content\/plugins\/seo-by-rank-math1\/assets\/admin\/img\/icon-gif.png","path":"\/home\/strauman\/public_html\/fa\/wp-content\/plugins\/seo-by-rank-math1\/assets\/admin\/img\/icon-gif.png","position":"middle_center"}},"defautOgImage":"https:\/\/straumanniran.com\/fa\/wp-content\/plugins\/seo-by-rank-math1\/assets\/admin\/img\/social-placeholder.jpg","customPermalinks":true,"isUserRegistered":false,"autoSuggestKeywords":false,"connectSiteUrl":"https:\/\/rankmath.com\/auth?site=https%3A%2F%2Fstraumanniran.com%2Ffa&r=https%3A%2F%2Fstraumanniran.com%2Ffa%2Fwp-json%2Fwp%2Fv2%2Fpages%2F621%3Fnonce%3D33ff5c44cd","maxTags":5,"trendsIcon":"<\/svg>","showScore":true,"siteFavIcon":"https:\/\/straumanniran.com\/fa\/wp-content\/uploads\/2025\/01\/cropped-struman-favicon-32x32.png","canUser":{"general":false,"advanced":false,"snippet":false,"social":false,"analysis":false,"analytics":false,"content_ai":false},"isPro":false,"is_front_page":false,"trendsUpgradeLink":"https:\/\/rankmath.com\/pricing\/?utm_source=Plugin&utm_medium=CE%20General%20Tab%20Trends&utm_campaign=WP","trendsUpgradeLabel":"\u0627\u0631\u062a\u0642\u0627","trendsPreviewImage":"https:\/\/straumanniran.com\/fa\/wp-content\/plugins\/seo-by-rank-math1\/assets\/admin\/img\/trends-preview.jpg","currentEditor":false,"homepageData":{"assessor":{"powerWords":[],"diacritics":true,"researchesTests":["contentHasTOC","contentHasShortParagraphs","contentHasAssets","keywordInTitle","keywordInMetaDescription","keywordInPermalink","keywordIn10Percent","keywordInContent","keywordInSubheadings","keywordInImageAlt","keywordDensity","keywordNotUsed","lengthContent","lengthPermalink","linksHasInternal","linksHasExternals","linksNotAllExternals","titleStartWithKeyword","titleSentiment","titleHasPowerWords","titleHasNumber","hasContentAI"],"hasBreadcrumb":false,"serpData":{"title":"%sitename% %page% %sep% %sitedesc%","description":"","titleTemplate":"%sitename% %page% %sep% %sitedesc%","descriptionTemplate":"","focusKeywords":"","breadcrumbTitle":"Home","robots":{"index":true},"advancedRobots":[],"facebookTitle":"","facebookDescription":"","facebookImage":"","facebookImageID":""}}},"tocTitle":"Table of Contents","tocExcludeHeadings":[],"listStyle":"ul"},"_links":{"self":[{"href":"https:\/\/straumanniran.com\/fa\/wp-json\/wp\/v2\/pages\/621","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/straumanniran.com\/fa\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/straumanniran.com\/fa\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/straumanniran.com\/fa\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/straumanniran.com\/fa\/wp-json\/wp\/v2\/comments?post=621"}],"version-history":[{"count":5,"href":"https:\/\/straumanniran.com\/fa\/wp-json\/wp\/v2\/pages\/621\/revisions"}],"predecessor-version":[{"id":4937,"href":"https:\/\/straumanniran.com\/fa\/wp-json\/wp\/v2\/pages\/621\/revisions\/4937"}],"wp:attachment":[{"href":"https:\/\/straumanniran.com\/fa\/wp-json\/wp\/v2\/media?parent=621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}